Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Capital Expenditures (2019 - 2025)

Historic Capital Expenditures for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $42000.0.

  • IDEAYA Biosciences' Capital Expenditures fell 9080.96% to $42000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 1269.13%. This contributed to the annual value of $3.9 million for FY2024, which is 6288.01% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Capital Expenditures stood at $42000.0 for Q3 2025, which was down 9080.96% from $663000.0 recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Capital Expenditures ranged from a high of $1.8 million in Q2 2022 and a low of $42000.0 during Q3 2025
  • Moreover, its 5-year median value for Capital Expenditures was $704500.0 (2023), whereas its average is $797055.6.
  • As far as peak fluctuations go, IDEAYA Biosciences' Capital Expenditures soared by 293939.39% in 2021, and later plummeted by 9080.96% in 2025.
  • Over the past 5 years, IDEAYA Biosciences' Capital Expenditures (Quarter) stood at $605000.0 in 2021, then skyrocketed by 81.98% to $1.1 million in 2022, then dropped by 23.89% to $838000.0 in 2023, then soared by 31.5% to $1.1 million in 2024, then plummeted by 96.19% to $42000.0 in 2025.
  • Its Capital Expenditures was $42000.0 in Q3 2025, compared to $663000.0 in Q2 2025 and $1.3 million in Q1 2025.